(Q33183531)

23 July 2017

1 reference

title

New and emerging therapies for sepsis (English)

1 reference

23 July 2017

0 references

Daniel P Healy

1

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Annals of Pharmacotherapy

23 July 2017

published in

1 reference

23 July 2017

volume

36

1 reference

23 July 2017

issue

4

1 reference

23 July 2017

page(s)

648-654

1 reference

The sirens' songs of confirmatory sepsis trials: selection bias and sampling error.

23 July 2017

cites work

1 reference

21 January 2018

Why sepsis trials fail

1 reference

Adjunctive therapy for septic shock: a review of experimental approaches

21 January 2018

1 reference

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

21 January 2018

1 reference

Pathogenetic mechanisms of septic shock

21 January 2018

1 reference

Activation of coagulation after administration of tumor necrosis factor to normal subjects

21 January 2018

1 reference

Vascular-bed--specific hemostasis and hypercoagulable states

21 January 2018

1 reference

Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis

21 January 2018

1 reference

Has the mortality of septic shock changed with time

21 January 2018

1 reference

Epidemiology of sepsis: an update

21 January 2018

1 reference

The endothelium in sepsis: source of and a target for inflammation

21 January 2018

1 reference

Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock

21 January 2018

1 reference

Coagulation in severe sepsis: a central role for thrombomodulin and activated protein C.

21 January 2018

1 reference

Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation

21 January 2018

1 reference

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

Recombinant human activated protein C: a system modulator of vascular function for treatment of severe sepsis

21 January 2018

1 reference

Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis

21 January 2018

1 reference

Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned

21 January 2018

1 reference

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

21 January 2018

1 reference

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A283

1 reference

23 July 2017

1 reference